Clinical Guides
Scrub Typhus
A clinically focused Indian guide to early recognition, time-sensitive diagnosis and antimicrobial management of scrub typhus, with explicit test, resistance and surveillance limitations.
MedNext Academy | 14 min read
Scrub Typhus
A clinically focused Indian guide to early recognition, time-sensitive diagnosis and antimicrobial management of scrub typhus, with explicit test, resistance and surveillance limitations.
Summary
Scrub typhus is an acute febrile illness caused by Orientia tsutsugamushi and transmitted by the bite of infected larval trombiculid mites, commonly called chiggers. Exposure occurs in focal mite habitats associated with scrub vegetation, farms, forest margins, plantations and other outdoor environments across parts of India. Fever, headache and myalgia are common; an eschar, rash or lymphadenopathy may help, but none is consistently present. The infection can progress after the first untreated week to pneumonitis, acute respiratory distress syndrome, hepatitis, acute kidney injury, meningoencephalitis, myocarditis, shock and multiorgan dysfunction.
Diagnosis is time-sensitive and probabilistic. Search carefully for an eschar in covered areas, record exposure and illness day, and test serious co-endemic alternatives in parallel. PCR on eschar material or blood is most useful early but may be unavailable. IgM ELISA becomes more informative after the first week and needs locally validated cut-offs; paired serology is stronger evidence than one titre. Weil-Felix has poor sensitivity and specificity and must not be used as a sole rule-in or rule-out test. A rapid defervescence after doxycycline is supportive at most, never diagnostic by itself.
When clinical suspicion is substantial, treatment should not be delayed for confirmatory testing, especially in a deteriorating patient. Doxycycline is a principal therapy; azithromycin has important roles, including pregnancy pathways. A multicentre Indian randomized trial found intravenous doxycycline plus azithromycin superior to either alone for a composite outcome in severe disease, but it excluded pregnancy and younger children and did not show a mortality difference. Treatment selection, duration and organ support require current local policy and specialist judgement. This reviewed draft has been reviewed by the MedNext Clinical Team.
How Common Is It?
Scrub typhus is endemic across the Asia-Pacific region and is increasingly recognised as a cause of acute undifferentiated fever in India. Indian reports span the Himalayan belt, north and northeast, central states, the Western and Eastern Ghats and southern India, but case concentration changes with ecology, rainfall, agriculture, clinician awareness and access to IgM or molecular testing. The classical geographic triangle is a teaching model rather than a patient-level exclusion rule; travel, local surveillance and the actual exposure setting are more useful than a rigid map.
There is no single contemporary national incidence that can be applied to every Indian district. Surveillance counts are affected by different case definitions, locally chosen IgM optical-density thresholds, when blood is collected, referral patterns and whether eschars are actively searched for. Hospital studies overrepresent severe disease, while patients treated empirically may never enter a laboratory-confirmed denominator. A rise in reports can reflect true transmission, improved diagnostic availability or both. Conversely, an outbreak can be missed when cases are coded as dengue, enteric fever, pneumonia, hepatitis or encephalitis.
Seasonality varies regionally with the activity of chigger larvae and human exposure. Rainy or post-monsoon peaks are described in several Indian settings, but tropical transmission need not stop outside a stated season. Burden should be monitored through suspected, probable and confirmed categories, hospital admission, organ support, deaths, pregnancy outcomes and diagnostic delay. Local public-health teams need geographic clusters and exposure locations, not only home addresses. For an individual patient, absence of a declared outbreak or a national rate does not safely lower concern when compatible fever and organ involvement follow plausible rural or vegetated-terrain exposure.
Risk Factors
The central risk is entering a focal environment containing infected chiggers. Agricultural work, clearing vegetation, collecting firewood, military or field activity, trekking, camping, sitting or lying on grass, and living near scrubby vegetation can increase contact. Risk is highly patchy: a small mite-infested focus may matter more than broad district residence. Chiggers do not fly and scrub typhus is not ordinarily passed person to person. Ask about the precise activity, location, clothing, ground contact and timing rather than using the vague label rural exposure.
An eschar develops at the inoculation site in some patients but can be painless and hidden. Examine axillae, groin, inframammary folds, waistband, genital or perineal region, scalp and other covered sites with consent, privacy and a chaperone when appropriate. Visibility can differ with skin pigmentation and lesion stage. Failure to find an eschar does not exclude infection, while a necrotic lesion has alternative causes. Rash may also be absent. Neither clue should override physiology or the broader differential.
Delayed therapy is associated with progression to severe disease. Older age, pregnancy, diabetes, chronic cardiac, pulmonary, hepatic or renal illness, and presentation with hypotension, altered sensorium or organ injury increase clinical vulnerability, although no score replaces repeated assessment. Travel distance, delayed referral and limited PCR, intensive care or dialysis access amplify risk. No licensed human vaccine is routinely available. Protective clothing, footwear, repellents used according to product instructions, treated gear and avoiding direct contact with dense vegetation can reduce bites. Routine self-directed antibiotic prophylaxis is not justified by current robust evidence and risks adverse effects and antimicrobial misuse.
Diagnosis
Scrub typhus diagnosis combines epidemiology, syndrome, illness timing and laboratory evidence. Do not wait for a perfect test in severe compatible illness, but collect appropriate specimens before antibiotics when that causes no harmful delay.
History
Record onset and progression of fever, headache, myalgia, cough, breathlessness, vomiting, abdominal pain, rash, jaundice, reduced urine, bleeding, confusion, seizure and hearing or neurological symptoms. Ask about farm, forest, plantation, grass, trekking, military or disaster-relief exposure and the exact district and date. Elicit malaria, dengue, leptospirosis and enteric-fever risks, antibiotics already received, pregnancy, age, comorbidity and drug allergy. A careful private history supports a consented search for hidden eschar sites.
Examination
Measure temperature, pulse, blood pressure, respiratory rate, oxygen saturation, perfusion, urine output and mental state. Search skin systematically for an eschar and rash; assess lymph nodes, jaundice, petechiae and oedema. Examine lungs for pneumonitis or ARDS, heart for myocarditis, abdomen for hepatosplenomegaly, and nervous system for meningism, encephalopathy or focal deficit. Repeat examination because organ dysfunction may evolve after initial nonspecific fever.
Investigations
Obtain CBC, platelets, creatinine, electrolytes, liver tests, glucose and urinalysis; add blood gas, lactate, coagulation, ECG, troponin, chest imaging, cultures and CSF studies as indicated. PCR on eschar swab or tissue and whole blood is specific and most useful early. IgM ELISA is more accessible but needs illness-day interpretation and locally validated cut-off; paired acute and convalescent serology is stronger. IFA is a reference serologic method but access and standardisation limit routine use. Weil-Felix is insensitive and nonspecific. Test co-endemic dangerous alternatives in parallel.
Differential Diagnosis
Dengue may cause fever, rash, thrombocytopenia, hepatitis and shock; serial haematocrit, warning signs and illness-day-appropriate antigen or antibody tests support distinction. Malaria requires prompt microscopy or a quality rapid test according to local pathways, and a positive result does not eliminate co-infection. Leptospirosis is supported by floodwater or animal-urine exposure, conjunctival suffusion, jaundice, kidney injury or pulmonary haemorrhage. Enteric fever, bacterial sepsis, influenza, COVID-19 and acute viral hepatitis remain common alternatives. Empirical doxycycline must not stop blood cultures or focused source assessment when feasible.
Neurological scrub typhus overlaps with bacterial meningitis, viral encephalitis, cerebral malaria, tuberculosis, metabolic encephalopathy and toxin or drug effects. Pneumonitis and ARDS overlap with severe pneumonia, leptospirosis, influenza and cardiogenic pulmonary oedema. Myocarditis, acute coronary syndromes and arrhythmia require cardiovascular assessment rather than attribution to fever. Acute kidney injury can arise from shock, malaria, leptospirosis, nephrotoxic medicines or primary renal disease. Pregnancy adds obstetric sepsis, malaria and pregnancy-specific liver or hypertensive disorders.
Other rickettsioses may produce fever, rash or eschar and can cross-react serologically. An eschar differential includes anthrax, ecthyma, spider or arthropod injury, tularemia in relevant travel, fungal infection and traumatic necrosis. A rapid fall in fever after doxycycline occurs in several susceptible infections and is not a diagnostic test. Reconsider scrub typhus when fever or organ dysfunction persists despite an adequate active regimen, cultures identify another pathogen, serology is weak or mistimed, exposure is implausible, or a focal noninfectious process emerges.
Management
Assess severity immediately. Stabilise airway, breathing and circulation, check glucose and identify respiratory failure, shock, encephalopathy, acute kidney injury, hepatic dysfunction, myocarditis or bleeding. Provide oxygen, cautious balanced resuscitation, vasopressors, ventilation, dialysis, seizure care and other organ support according to physiology and current critical-care protocols. Transfer early when the first facility cannot provide serial monitoring or anticipated support. A suspected diagnosis should not delay sepsis care or treatment of a proven co-infection.
Start an effective antimicrobial promptly when scrub typhus is clinically plausible; NCDC, DHR-ICMR and CDC guidance all emphasize that laboratory confirmation should not delay treatment. Doxycycline is a principal first-line option. Azithromycin is an important alternative and is favoured in Indian pregnancy guidance. Exact drug, dose, route and course require age or weight, pregnancy, enteral tolerance, severity, allergy, organ function and current institutional policy. Review response within forty-eight to seventy-two hours while remembering that defervescence is not proof of diagnosis.
Severe scrub typhus requires specialist-led intravenous therapy and organ support. The 2023 Indian multicentre INTREST trial found combination intravenous doxycycline and azithromycin reduced a composite of death at day 28, persistent complications at day seven or fever at day five compared with either monotherapy. Benefit was driven mainly by fewer persistent complications; mortality was similar, and the trial excluded pregnancy, breastfeeding, immunosuppression and younger children. It should inform, not mechanically dictate, every severe case. At discharge document completed therapy, organ recovery, pending paired serology, relapse warning, exposure prevention and public-health reporting.
Prescribing Information
Doxycycline prescribing requires a verified current formulary. Check age or weight, pregnancy or breastfeeding, swallowing ability, severe hepatic dysfunction, interacting medicines and previous tetracycline reaction. Give oral doses with adequate water while upright and separate from iron, calcium, magnesium or antacids by the recommended interval to reduce absorption problems; warn about oesophagitis, gastrointestinal upset and photosensitivity. Current CDC guidance supports doxycycline for suspected scrub typhus in children of all ages, whereas older Indian documents advise against it below eight years. This conflict must be resolved explicitly by the treating paediatric team, not silently averaged.
Indian guidance uses azithromycin in pregnancy; expert obstetric and infectious-disease review remains appropriate because maternal infection itself threatens pregnancy and evidence is limited. Check QT risk, electrolyte disturbance, interacting medicines and hepatic function. Intravenous delivery demands dilution and infusion procedures from a current hospital protocol. Chloramphenicol has serious marrow and other toxicity and is not a casual substitute. Rifampicin monotherapy is particularly problematic in India because it can partially treat or select resistance in unrecognised tuberculosis; ICMR's 2019 antimicrobial guideline strongly discourages that approach.
Do not interpret slower defervescence as proof of antimicrobial resistance. It may reflect late severe disease, inadequate absorption, wrong diagnosis, co-infection or an untreated complication. Reports of reduced response are geographically and methodologically limited, and routine susceptibility testing is not widely available. Avoid unnecessary broad-spectrum combinations once cultures and assessment clarify the syndrome. The chemoprophylaxis schedules reproduced in older Indian alerts are not supported by a current universal recommendation; prophylaxis should occur only under a competent public-health or occupational protocol for a defined exceptional exposure.
When to Refer
Refer urgently for dyspnoea, hypoxaemia, pulmonary infiltrates, haemoptysis, hypotension, poor perfusion, oliguria, rapidly rising creatinine, jaundice with organ dysfunction, bleeding, confusion, meningism, seizure, focal deficit, chest pain, arrhythmia or syncope. ARDS, meningoencephalitis, myocarditis, shock and multiorgan dysfunction need secondary or tertiary care. Begin active treatment before transfer when scrub typhus is strongly suspected and this is within current protocol; document the drug, dose, time, specimens and physiological response.
Critical-care involvement is needed for respiratory support, vasopressors, severe metabolic disturbance or rapidly progressive organ failure. Nephrology review is appropriate for severe acute kidney injury, refractory hyperkalaemia or acidosis, fluid overload or dialysis indications. Neurology, cardiology and hepatology input follows the dominant complication. Pregnant patients need obstetric and infectious-disease collaboration, with fetal assessment according to gestation. Children with poor intake, respiratory signs, altered behaviour, seizure or organ injury require paediatric management rather than an adult regimen scaled casually.
Laboratory referral may be needed for validated IgM testing, PCR or paired serology. Send illness day, specimen type and prior antibiotic exposure. Notify cases and clusters through the current state or Integrated Disease Surveillance Programme route, especially when several patients share a village, farm, field, school, worksite or field-camp exposure. Post-discharge follow-up should confirm renal, liver, respiratory and neurological recovery and review any persistent hearing, cognitive or functional symptoms. Referral thresholds should be lower when transport is difficult or reliable reassessment cannot be guaranteed.
Red Flags
Respiratory deterioration is a major danger. New tachypnoea, falling oxygen saturation, increasing work of breathing, diffuse infiltrates or haemoptysis can indicate pneumonitis, ARDS, pulmonary haemorrhage or another co-infection. Do not wait for serology to turn positive. Hypotension, cold extremities, delayed capillary refill, rising lactate, confusion and falling urine output indicate circulatory failure. A transient fever response after an antibiotic does not make an unstable patient safe for discharge.
Neurological warning signs include severe headache with meningism, drowsiness, agitation, seizure, focal weakness, ataxia or reduced consciousness. Cardiac red flags are chest pain, disproportionate tachycardia, new ECG change, arrhythmia, heart failure or syncope. Renal red flags include oliguria, hyperkalaemia, acidosis and fluid overload. Marked jaundice, hypoglycaemia, coagulopathy, rapidly falling platelets or bleeding require urgent investigation and broadened differential diagnosis. Pregnancy with maternal instability, bleeding, contractions or reduced fetal movement needs immediate obstetric assessment.
Treatment hazards also require escalation: anaphylaxis, severe rash, persistent vomiting preventing oral absorption, oesophageal pain after doxycycline, significant QT prolongation with azithromycin, cytopenia with marrow-toxic therapy or new organ injury. Lack of improvement after forty-eight to seventy-two hours should trigger review of adherence, dose, absorption, sampling, diagnosis, co-infection and complications rather than reflex antibiotic stacking. An absent eschar, negative early antibody result or initially normal chest radiograph does not remove risk when exposure and evolving physiology remain compatible.
Indian Clinical Context
The NCDC 2024 CD Alert and DHR-ICMR national guideline provide Indian case-recognition, laboratory and treatment frameworks. Their strongest durable messages are careful eschar search, locally interpreted IgM, early PCR when available, prompt empirical treatment when suspicion is meaningful and urgent referral for organ dysfunction. District and medical-college laboratories differ in test platform, cut-off and turnaround. Clinicians must record assay details and illness day; a commercial positive without validation should not automatically become a confirmed surveillance case.
India's acute-fever landscape makes antimicrobial stewardship difficult. Dengue, malaria, leptospirosis, enteric fever and bacterial sepsis overlap, and co-infection can occur. Starting doxycycline for credible scrub typhus does not justify abandoning malaria testing, cultures or organ-focused investigation. Conversely, waiting for every result in an unstable exposed patient is unsafe. Rifampicin monotherapy should be avoided where tuberculosis is endemic. Community antibiotic distribution and prophylaxis can obscure diagnoses, cause adverse effects and exert selection pressure without replacing chigger protection or early clinical review.
Important version conflicts must be visible. The 2024 alert substantially reproduces older DHR-ICMR positions, including Weil-Felix use, avoidance of doxycycline under eight and detailed prophylaxis schedules. CDC 2024 regards Weil-Felix as too inaccurate and supports doxycycline for all ages; the Indian severe-disease RCT adds combination evidence but excluded pregnant patients and younger children. These are not resolved by choosing whichever sentence is convenient. Current national, state, paediatric, obstetric and institutional policies must be reconciled and documented. This guide makes no all-India incidence claim, no universal resistance claim and no assurance of uniform PCR access.
NMC Competency Mapping
The 2024 NMC microbiology curriculum maps scrub typhus most directly to MI8.3, which addresses rickettsial infections and laboratory diagnosis. MI8.1 supports zoonotic bacterial concepts and MI8.8 supports prevention and infection-control principles. General Medicine integration covers acute undifferentiated fever, sepsis, respiratory failure, encephalopathy, kidney injury and rational antimicrobial use; Community Medicine adds surveillance, outbreak investigation, environmental risk and communication. Curricular mapping is educational and does not authorize unsupervised antibiotic or critical-care decisions.
A competent learner should identify Orientia tsutsugamushi, chigger transmission and focal scrub habitat; obtain a detailed agricultural, forest, grass and travel history; and search consented covered skin sites for an eschar. They should recognise that eschar and rash may be absent and construct an Indian differential including dengue, malaria, leptospirosis, enteric fever and bacterial sepsis. Severity assessment should include oxygenation, perfusion, urine output, mental state and cardiac, hepatic or bleeding features.
Laboratory competence means relating PCR, IgM ELISA, IFA and paired sera to illness day, explaining local cut-off and background-antibody problems, and rejecting Weil-Felix as a reliable standalone test. Management competence includes sampling without harmful delay, timely active antibiotic therapy, stewardship, organ support, referral and pregnancy or paediatric escalation. Prevention includes clothing, repellents, reducing direct vegetation contact and prompt cluster reporting. Learners should be rewarded for explaining uncertainty and guideline conflict rather than reciting an obsolete prophylaxis schedule as universal practice.
Key Exam Pearls for NEET PG
Scrub typhus is caused by Orientia tsutsugamushi and transmitted by the larval stage of trombiculid mites. Fever, headache, myalgia, lymphadenopathy, rash and eschar are classic, but eschar may be absent or hidden. Examine axillae, groin, inframammary and waistband regions with consent. Severe untreated disease can cause interstitial pneumonitis or ARDS, hepatitis, acute kidney injury, myocarditis, shock and meningoencephalitis. The differential in India includes dengue, malaria, leptospirosis and enteric fever.
PCR on eschar material or blood is most useful early. IgM ELISA becomes more useful toward the end of the first week, but cut-offs require regional validation and past antibody can confound a single result. IFA is a reference serological method; paired samples showing a rise are stronger than a lone titre. Weil-Felix OXK is historically associated with scrub typhus but lacks adequate sensitivity and specificity and should not be the sole diagnostic basis. Clinical improvement with doxycycline is not a confirmatory test.
Treat on meaningful clinical suspicion rather than waiting for perfect laboratory confirmation. Doxycycline is a principal treatment; azithromycin is important in pregnancy pathways and as an alternative. For severe disease, an Indian randomized trial supports intravenous doxycycline plus azithromycin over either alone for a composite clinical outcome, but not as an unqualified rule for pregnancy or young children. Rifampicin monotherapy is inappropriate in tuberculosis-endemic India. No licensed vaccine is routinely available; protection focuses on avoiding chigger exposure and prompt recognition.
Frequently Asked Questions
Can scrub typhus be excluded when no eschar is found on examination?
No. Eschars are helpful when present but may be absent, small, painless, obscured by skin pigmentation or hidden in axillae, groin, inframammary folds, scalp, waistband or perineal areas. Perform a consented systematic examination with privacy and a chaperone where appropriate. Base decisions on exposure, illness day, physiology and tests, not one skin finding.
Why is the Weil-Felix test insufficient for diagnosing scrub typhus?
Weil-Felix depends on cross-reacting Proteus antigens and has poor sensitivity and specificity. Background titres also differ by region. Older Indian guidance retained it as an inexpensive presumptive tool, but current CDC guidance does not recommend it as a diagnostic assay. A positive or negative result must never delay treatment or replace validated IgM, PCR, paired serology and clinical assessment.
Should treatment wait until scrub typhus PCR or IgM results are available?
Not when the syndrome and exposure create meaningful suspicion, particularly if the patient is deteriorating. Collect appropriate specimens first if that causes no harmful delay, start an active antibiotic under current local policy, and continue evaluating dengue, malaria, leptospirosis, enteric fever and bacterial sepsis. Review response and results rather than treating defervescence as proof of the diagnosis.
Does the severe scrub typhus trial mean every patient needs doxycycline plus azithromycin?
No. The Indian INTREST trial enrolled hospitalized patients aged at least fifteen with organ involvement and found combination intravenous therapy improved a composite outcome compared with either monotherapy. Mortality was similar, and pregnancy, breastfeeding, immunosuppression and younger children were excluded. Uncomplicated disease, special populations, allergy and local protocols therefore require separate decisions.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic